Digital piracy, especially in the streaming sector, has caused significant economic impacts on Brazil’s audiovisual industry and the state. Operation 404, one of the largest anti-piracy initiatives in the country, has played a key role in combating online piracy. As we will see below, the seventh phase of the operation, carried out this week (Sept/2024), reinforces the crackdown on illegal platforms that distribute audiovisual content criminally.
On August 27, 2024, the 3rd Chamber of the Brazilian Superior Court of Justice addressed the legal controversy concerning whether YouTube, an internet application provider owned by Google, can remove, suspend, or make user content unavailable when it violates its applicable terms of use. The court also sought to determine if such content moderation aligns with Brazilian law, particularly regarding freedom of expression, censorship prohibition, and the liability of service providers.
This weekend marked the 40th anniversary edition ofRock in Rio, recognized as one ofthe world's largest music festivals, which expects to attract around 700,000 people over its seven-day run.
On August 13, 2024, the First Panel of the STJ (Superior Court of Justice) ruled that ANVISA – National Health Surveillance Agency – does not have the legal authority to impose restrictions on drug advertising. According to the Court, the regulatory agency lacks the authority to create rules that exceed the provisions of Law 9.294/1996, which regulates the advertising of pharma and related products.
The Brazilian Patent and Trademark Office "INPI" obtained an injunction from the 6th Federal Court of Campinas - São Paulo State against a local company to remove the website https://portalinpi.com.br, which is very similar to the official INPI website, https://inpi.gov.br. The injunction also requires the company to cease using the INPI acronym and logo on its physical or virtual advertising platforms, including websites and social media.
Over the last few years, the spread of counterfeit goods on online sales platforms has become a noteworthy concern for Intellectual Property (“IP”) owners, manufacturers, consumers, and regulatory authorities.
Imposter Syndrome has been defined as “the persistent inability to believe that one’s success is deserved or has been legitimately achieved as a result of one’s own efforts or skills.” Generally, this means feeling not good enough or deserving enough in or for your role – thinking of yourself as a fraud.
Within the industrial property discussion environment, more specifically with regard to innovation and technology protection through patents, companies that manufacture generics and similar drugs for many years were considered rivals to pharmaceutical laboratories holding patents. They were often nicknamed the “copy industry”, despite the fact that generic manufacturing is a legal and regulated activity.
Environmental, Social, and Governance (ESG) criteria are increasingly important for businesses across all sectors, including law firms.
For some years now, the litigation scenario involving SEPs in Brazil has been gaining relevance and the number of lawsuits filed by entities holding patents, sometimes NPEs (non-practicing entities), and some other companies that both hold essential patents and implement them, has been growing exponentially.